{"id":"W2891861976","doi":"10.1002/hon.2560","title":"Outcome of patients with relapsed or refractory anaplastic large cell lymphoma who have failed brentuximab vedotin","year":2018,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Refractory (planetary science); Anaplastic large-cell lymphoma; Internal medicine; Salvage therapy; Surgery; Gastroenterology; Lymphoma; Chemotherapy; Oncology; CD30","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001376844,0.0002951705,0.001252915,0.0001096259,0.00009494453,0.000006740683,0.0001335221,0.0003747059,0.001154738],"category_scores_gemma":[0.0003230452,0.000158012,0.0001379427,0.0001799449,0.0003537213,0.00005210978,0.0001074959,0.0001150721,0.0002325001],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003532847,"about_ca_system_score_gemma":0.000227231,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001894136,"about_ca_topic_score_gemma":0.0001208746,"domain_scores_codex":[0.9978548,0.0001424358,0.0006778017,0.000485847,0.0003291946,0.0005099371],"domain_scores_gemma":[0.9980593,0.0006477459,0.0003644901,0.0003999581,0.0002751501,0.00025333],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006168655,0.01715753,0.970431,0.0001260623,0.0001270724,0.0007219661,0.0001598042,1.120415e-7,0.0000151109,0.0004596996,0.00262171,0.002011225],"study_design_scores_gemma":[0.04591525,0.0254436,0.902164,0.000102228,0.0003119927,0.0000918808,0.0001338688,0.00006498853,0.001583594,0.00003503063,0.02393245,0.0002210816],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990899,0.00009516723,0.00007286422,0.0002839714,0.0001673485,0.000636988,0.0000416079,0.00006551404,0.00773752],"genre_scores_gemma":[0.9970659,0.00002126212,0.00129798,0.0007906722,0.00005937388,0.00008270919,0.0000655703,0.00002481695,0.0005917052],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06826703,"threshold_uncertainty_score":0.9997584,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02367617166302798,"score_gpt":0.3013416210523374,"score_spread":0.2776654493893094,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}